Superworth

Merck PE ratio MRK

Share price divided by earnings per share over the last twelve months, since 2010.

Today, Nov 3, 2026
150×
10-year median
25.0×
Against its 10-year history
100th
percentile: 0 is its lowest day, 100 its highest
10-year range
11.1× to 154×
Peer median
40.9×

Merck's PE ratio is 150× as of Nov 3, 2026: a share price of $145.73 against $0.97 of earnings per share over the last twelve months.

That is above its ten-year median of 25.0×, higher than on 100% of days in the last ten years.

Over that time it ranged from 11.1× in May 2025 to 154× in Oct 2026.

The median for 8 large drugmakers of a similar size is 40.9×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far153×14.1×154×
202514.1×11.1×20.8×
202420.9×18.9×146×
202360.6×17.1×90.3×
202218.5×13.2×28.8×
202127.1×15.7×40.2×
202017.3×16.8×24.3×
201924.4×22.0×62.1×
201858.0×50.8×141×
201752.1×29.2×52.2×
201628.6×12.5×37.4×
201513.4×13.1×33.0×
201430.3×27.3×38.0×
201331.7×17.9×31.7×
201217.7×15.8×27.3×
201126.2×11.0×129×
201012.3×9.8×12.5×

Against its peers

Companies in Drug Manufacturers - General nearest Merck's size, closest first, today.

CompanyPE ratio
MRKMerck150×
ABBVAbbVie49.8×
AMGNAmgen29.0×
GILDGilead Sciencesn/m
JNJJohnson & Johnson40.9×
PFEPfizer40.6×
BMYBristol-Myers Squibb14.0×
LLYEli Lilly and46.5×
BIIBBiogen44.3×
Peer median40.9×

Where Merck ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Merck

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.